ClinConnect ClinConnect Logo
Search / Trial NCT01977274

Predictive Clinical and Biological Parameters in Gynecological Cancer

Launched by INSTITUT PAOLI-CALMETTES · Oct 30, 2013

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Ovarian, Endometrium, Cervix Cancer

ClinConnect Summary

This clinical trial is studying different factors that might help predict how gynecological cancers, like ovarian, endometrial, and cervical cancer, behave. Researchers are looking at things like genetics and proteins in the body to see if they can find patterns that help doctors understand these cancers better. The trial is currently recruiting female participants aged 18 and older who have a suspicion of having gynecological cancer and are willing to sign a consent form to take part.

If you join this study, you can expect to undergo tests that will help gather information about your condition. It’s important to note that this trial is not for those who are dealing with an emergency or those who have been diagnosed with cancers other than the specified gynecological types. This research aims to improve how doctors can predict and treat these cancers in the future, ultimately benefiting patients like you.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • gynecological cancer suspicion
  • age \> 18
  • signed informed consent
  • Exclusion Criteria:
  • - emergency
  • Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

About Institut Paoli Calmettes

Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.

Locations

Marseille, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials